GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®
Public ClinicalTrials.gov record NCT02514772. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double- Blind, Controlled, Parallel-group, Multicenter Study to Assess the Safety and Immunogenicity of Transitioning to GP2013 or Re-treatment With Rituxan® or MabThera® in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study objective is to identify potential safety risks of the transition from US-licensed Rituxan® or EU-approved MabThera® to GP2013 (proposed biosimilar product) as compared to continuous treatment with the originator product in terms of general safety and immunogenicity.
Study identification
- NCT ID
- NCT02514772
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 107 participants
Conditions and interventions
Conditions
Interventions
- GP2013 - A Proposed biosimilar rituximab Biological
- Originator rituximab - Rituxan ® or MabThera ® Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2015 (Type not available)
- Primary completion
- Jul 2016 (Actual)
- Completion
- Oct 2016 (Actual)
- Last update posted
- Dec 28, 2017
2015 – 2016
United States locations
- U.S. sites
- 39
- U.S. states
- 18
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rheumatology Associates of North Alabama, PC | Huntsville | Alabama | 35801 | — |
| Clinical and Translational Research Center of Alabama PC | Tuscaloosa | Alabama | 35406 | — |
| Arizona Arthritis & Rheumatology Research, PLLC | Glendale | Arizona | 85306 | — |
| Arizona Arthritis and Rheumatology Research, PLLC | Mesa | Arizona | 85202 | — |
| Arizona Arthritis & Rheumatology Research, PLLC | Phoenix | Arizona | 85032 | — |
| Arizona Arthritis and Rheumatology Research, PLLC | Phoenix | Arizona | 85037 | — |
| TriWest Research Associates, LLC | El Cajon | California | 92020 | — |
| Valerius Medical Group and Research Center of Greater Long Beach, Inc | Long Beach | California | 90806 | — |
| Pacific Arthritis Center Medical Group | Santa Maria | California | 93454 | — |
| Westlake Medical Research Inc. | Thousand Oaks | California | 91360 | — |
| Inland Rheumatology and Osteoporosis Medical Group | Upland | California | 91786 | — |
| Arthritis Associates & Osteoporosis Center of Colorado Springs | Colorado Springs | Colorado | 80920 | — |
| Denver Arthritis Clinic | Denver | Colorado | 80230 | — |
| Bay Area Arthritis and Osteoporosis | Brandon | Florida | 33511 | — |
| Sunrise Research Institute, Inc. | Miami | Florida | 33130 | — |
| Omega Research Consultants, LLC | Orlando | Florida | 32804 | — |
| Arthritis Center | Palm Harbor | Florida | 34684 | — |
| Arthritis Research of Florida, Inc. | Palm Harbor | Florida | 34684 | — |
| Southwest Florida Clinical Research Center | Tampa | Florida | 33609 | — |
| Florida Medical Clinic, PA | Zephyrhills | Florida | 33542 | — |
| Idaho Arthritis and Osteoporosis Clinic | Meridian | Idaho | 83642 | — |
| Bluegrass Community Research, Inc. | Lexington | Kentucky | 40504 | — |
| Arthritis and Rheumatology Consultants, P.A. | Edina | Minnesota | 55435 | — |
| North Mississippi Medical Clinical, Inc | Tupelo | Mississippi | 38801 | — |
| Physician Research Collaboration, LLC | Lincoln | Nebraska | 68516 | — |
| Innovative Health Research | Las Vegas | Nevada | 89128 | — |
| Arthritis and Osteoporosis Consultants of The Carolinas | Charlotte | North Carolina | 28207 | — |
| Physicians East, PA | Greenville | North Carolina | 27834 | — |
| STAT Research Inc. | Dayton | Ohio | 45417 | — |
| Arthritis & Rheumatology Center of Oklahoma, PLLC | Oklahoma City | Oklahoma | 73103 | — |
| Health Research of Oklahoma | Oklahoma City | Oklahoma | 73103 | — |
| Altoona Center For Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Emkey Arthritis and Osteoporosis Clinic, PC | Wyomissing | Pennsylvania | 19610 | — |
| Low Country Rheumatology, PA | Charleston | South Carolina | 29406 | — |
| Piedmont Arthritis Clinic, PA | Greenville | South Carolina | 29601 | — |
| Amarillo Center for Clinical Research, Ltd. | Amarillo | Texas | 79124 | — |
| Pioneer Research Solutions, Inc. | Houston | Texas | 77099 | — |
| Arthritis and Osteoporosis Center of South Texas | San Antonio | Texas | 78232 | — |
| Rheumatic Disease Center | Glendale | Wisconsin | 53217 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 26 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02514772, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 28, 2017 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02514772 live on ClinicalTrials.gov.